oxazoles has been researched along with dipyridamole in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borasi, G; Pallestrini, EA; Sperati, G | 1 |
| Fabris, F; Pernigotti, L | 1 |
| Belli, R; Biasci, R; Bruna, C; Caruzzo, C; Gaschino, G | 1 |
| Alessandri, C; Bartoli, F; Cordova, C; Mantovani, E; Marconi, W; Musca, A; Pittalis, F; Settembri, L | 1 |
| Bonaventi, C; Caneschi, S; Finzi, F | 1 |
| Borrelli, F; Caprino, L; Falchetti, R | 1 |
| Breddin, HK; Pauliks, V; Weichert, W | 1 |
| Bittner, G; Fischer, PH; Pamukcu, R; Willson, JK | 1 |
| Lui, MS; Weber, G; Zhen, YS | 1 |
| Durham, SK; Heran, CL; Megill, JR; Schumacher, WA; Steinbacher, TE | 1 |
| Arrobas, M; Caravaca, F; Cid, MC; Cubero, J; López-Minguez, JR; Miranda, MP; Pizarro, JL; Sanchez-Casado, E | 1 |
| Huang, Y; Kong, SK; Kwan, HY; Yao, X | 1 |
2 trial(s) available for oxazoles and dipyridamole
| Article | Year |
|---|---|
[Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
Topics: Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Oxazoles; Platelet Adhesiveness; Platelet Aggregation | 1979 |
Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.
Topics: Adult; Aged; Anemia; Aspirin; Dipyridamole; Erythropoietin; Female; Hemodynamics; Humans; Male; Middle Aged; Oxazoles; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ticlopidine; Time Factors; Uremia | 1995 |
10 other study(ies) available for oxazoles and dipyridamole
| Article | Year |
|---|---|
[The use of platelet aggregation-inhibiting drugs in central vestibular pathology caused by atherosclerotic vascular diseases].
Topics: Aspirin; Dipyridamole; Drug Evaluation; Humans; Intracranial Arteriosclerosis; Labyrinth Diseases; Oxazoles; Platelet Aggregation; Vestibule, Labyrinth | 1975 |
[Antiaggregant therapy in cerebrovascular insufficiency in the aged].
Topics: Aged; Aspirin; Blood Platelet Disorders; Dipyridamole; Drug Evaluation; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Oxazoles; Platelet Aggregation | 1979 |
Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterization.
Topics: Adsorption; Animals; Biocompatible Materials; Blood Proteins; Cellulose; Dipyridamole; Dogs; Female; Fibrinolytic Agents; Male; Nylons; Oxazoles; Platelet Aggregation; Silicone Elastomers; Surface Properties; Thrombosis | 1979 |
[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].
Topics: Adenosine Diphosphate; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Isoxsuprine; Male; Oxazoles; Platelet Aggregation; Recurrence | 1985 |
Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)aminoxazol (ditazol) on platelet aggregation, adhesiveness and bleeding time.
Topics: Adenosine; Adenosine Diphosphate; Adult; Analysis of Variance; Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Collagen; Dipyridamole; Drug Interactions; Epinephrine; Ethanol; Ethanolamines; Humans; Male; Mice; Middle Aged; Oxazoles; Phenylbutazone; Platelet Adhesiveness; Rabbits; Time Factors | 1973 |
Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Fibrinolytic Agents; Heparin; Lasers; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Molsidomine; Oxazoles; Platelet Aggregation; Propionates; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Sydnones; Thiophenes; Thrombosis; Ticlopidine | 1983 |
Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Topics: Antibiotics, Antineoplastic; Cell Cycle; Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Humans; Isoxazoles; Kinetics; Oxazoles; Ribonucleosides; Ribonucleotides | 1984 |
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazoles; Kinetics; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleosides | 1983 |
Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Aspirin; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery Thrombosis; Dipyridamole; Fibrinolytic Agents; Heparin; Male; Oxazoles; Propionates; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Ticlopidine; Triazoles; Warfarin | 1993 |
cGMP abolishes agonist-induced [Ca(2+)](i) oscillations in human bladder epithelial cells.
Topics: Acetylcholine; Alkaloids; Bradykinin; Calcium Signaling; Calcium-Transporting ATPases; Carbazoles; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dipyridamole; Drug Antagonism; Enzyme Inhibitors; Epithelial Cells; Humans; Indoles; Kinetics; Macrocyclic Compounds; Oxazoles; Phosphodiesterase Inhibitors; Urinary Bladder | 2001 |